PepsiCo (NASDAQ:PEP) PT Raised to $185.00 at Barclays
by The Cerbat Gem
The Cerbat Gem— PepsiCo (NASDAQ:PEP – Free Report) had its price target boosted by Barclays from $184.00 to $185.00 in a research note published on Thursday, Benzinga reports. They currently have an overweight rating on the stock. PEP has been the subject of several other research reports. Citigroup upgraded shares of PepsiCo from a neutral rating to a […]
The Cerbat Gem—Neurocrine Biosciences (NASDAQ:NBIX) PT Raised to $216.00 at Oppenheimer. Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price objective lifted by research analysts at Oppenheimer from $200.00 to $216.00 in a research report issued on Thursday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Oppenheimer’s target price would suggest a potential upside of 53.51% from the stock’s previous close. […]
The Cerbat Gem—Meritage Portfolio Management Raises Position in PepsiCo, Inc. (NASDAQ:PEP). Meritage Portfolio Management raised its holdings in shares of PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 4.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,206 shares of the company’s stock after purchasing an additional 307 shares during the period. Meritage […]
The Cerbat Gem—QUALCOMM (NASDAQ:QCOM) PT Raised to $140.00 at Wells Fargo & Company. QUALCOMM (NASDAQ:QCOM – Get Free Report) had its price target boosted by analysts at Wells Fargo & Company from $120.00 to $140.00 in a research report issued on Thursday, Benzinga reports. The brokerage presently has an “underweight” rating on the wireless technology company’s stock. Wells Fargo & Company‘s price objective points to a potential downside […]